Navigation Links
Rosetta Genomics and Weizmann Institute Scientists Identify Role of,microRNA in Cancer Suppression

utics. Since many diseases are caused by the abnormal activity of proteins, the ability to selectively regulate protein activity through microRNAs could provide the means to treat a wide range of human diseases. In addition, microRNA expression levels have been shown to be correlated with various disease states and to hold great potential as diagnostics and prognostic markers

About Rosetta Genomics

Rosetta Genomics is a leader in the development of microRNA-based diagnostics and therapeutics. Founded in 2000, the company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong IP position and strategic alliances with leading biotechnology companies, Rosetta Genomics is working to develop a full range of diagnostic and therapeutic products based on microRNAs. The company's primary focus is in the development of microRNA-based products to diagnose and treat different forms of cancer and infectious diseases. For more information please visit: www.rosettagenomics.com

Forward-Looking Statement Disclaimer

Various statements in this release concerning Rosetta's future expectations, plans and prospects, including without limitation, statements relating to the role of miRNAs in human physiology and disease and the potential of microRNAs in the development of therapeutics and diagnostic products constitute forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including risks related to: Rosetta's approach to discover and develop novel diagnostics products, which is unproven and may never lead to marketable products; Rosetta's
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Rosetta Genomics to Webcast Presentation at CE Unterberg, Towbin Emerging Growth Opportunities Conference
2. Actilyse (alteplase) Recommended by National Institute for Health and Clinical Excellence for Treatment of Acute Ischaemic Stroke
3. Positive Results Prompt US National Cancer Institute to Make Glivec Available to Patients in Post-Surgical GIST Study
4. Positive Results Prompt US National Cancer Institute to Make Gleevec Available To Patients in Post-Surgical Gist Study
5. Southern Research Institute to Present at the 2007 American Association For Cancer Research Annual Meeting
6. Sarasotas Roskamp Institute Announces Positive Safety Data in Human Clinical Study for Alzheimers Disease
7. Protox Announces Publication in Journal of the National Cancer Institute Supporting PRX302 as Treatment for Prostatic Diseases
8. Schepens Scientists Identify Key to Integrating Transplanted Nerve Cells Into Injured Tissue
9. Karmanos Physician-Scientists Examine Racial Disparities in Patients with Gynecologic Cancer
10. Scientists Implicate Gene in Vitiligo and Other Autoimmune Diseases
11. The Sturdier Sex?: Study by Pittsburgh Scientists Finds Female Stem Cells Work Better
Post Your Comments:
(Date:10/8/2008)... LYON, France, Oct. 8 /- Vical Inc...anded clinical data and new nonclinical data,demon...may be broadly,applicable in DNA- and protein-base...ncer vaccines. Alain P. Rolland, Pharm.D., Ph.D., ...nt, will present the data today,Wednesday, Octobe...
(Date:10/7/2008)... SAN DIEGO, Oct. 7 /- Prometheus L...ny, today announced findings from its,development ...y blood test,for irritable bowel syndrome (IBS). T...expression of particular biomarkers in blood sampl...ation of these biomarkers,combined with a proprie...
(Date:10/7/2008)...Study evaluates the efficacy of new device for det...ssed during colonoscopy, ORLANDO, Fla., Oct. 7 /P...erology Annual Scientific Meeting in Orlando (ACG ... MD presented results from a,multi-institutional c...hird,Eye(R) Retroscope(R), a new device that is de...
(Date:10/7/2008)... Results of FLEXX Trial Presented at the Osteoa...ld Congress, PARSIPPANY, N.J., Oct. 7 /PRNewswire...ed results from the FLEXX Trial of Osteoarthritis ...yaluronate), a highly pure,non-avian high molecula...IA-HA), is superior to intra-articular saline (IA-...
Breaking Medicine Technology:Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4Continua Health Alliance Provides Insight Into Next Generation of Digital Health at CONNECTIONS 28TM 29 20074 1Continua Health Alliance Provides Insight Into Next Generation of Digital Health at CONNECTIONS 28TM 29 20074 2North Castle Partners Names Dennis Lee of Octane Fitness CEO of the Year 20071 1North Castle Partners Names Dennis Lee of Octane Fitness CEO of the Year 20071 2North Castle Partners Names Dennis Lee of Octane Fitness CEO of the Year 20071 3Key to Angelina Like Cheeks 3F Add Volume to Deep Fat Compartment 20068 1Key to Angelina Like Cheeks 3F Add Volume to Deep Fat Compartment 20068 2Advanced Life Sciences Selected as Founding Member of the New NASDAQ OMX AeA Illinois Tech Index 5589 1Advanced Life Sciences Selected as Founding Member of the New NASDAQ OMX AeA Illinois Tech Index 5589 2Advanced Life Sciences Selected as Founding Member of the New NASDAQ OMX AeA Illinois Tech Index 5589 3Advanced Life Sciences Selected as Founding Member of the New NASDAQ OMX AeA Illinois Tech Index 5589 4
(Date:10/11/2008)...ot Pose Setback and Expects the 89-Year-Old ...ILLE, N.C., Oct. 11 /PRNewswire/ -- Evangelist Bil...treat, N.C. upon his release this,afternoon from M...ief stay.,He was admitted for observation after he...Friday., Mr. Graham,s physicians said that he suf...
(Date:10/10/2008)...orm of disease by 20 years after operation, study ...) -- Liver transplant patients have a higher incid...searchers in Finland. , In a new study publish..., researchers investigated the cancer risk pattern...elsinki University Central Hospital. The patients ...
(Date:10/10/2008)...ewswire/ -- Do you think that the blind,can,t use ...nd the October,17 open house at the Virginia Rehab..., and see how instructors there empower the blind ...ng lives through non-visual,techniques taught at t...nue, is holding an open house to,celebrate the gra...
(Date:10/10/2008)...RNewswire/ -- NuView Life Sciences Inc.,(NuView) h...ces Inc.,(Trace), including operations of the line... in Denton, Texas. The Trace facility produces,Cop...llium-201 used in,molecular imaging and nuclear me...d that "We are confident that by improving operati...
Breaking Medicine News(10 mins):Health News:Billy Graham Returns Home Following Hospital Observation 2Health News:Liver Transplant Patients at Higher Cancer Risk 2Health News:Virginia Rehabilitation Center for the Blind and Vision Impaired Celebrates Opening of New Student Dormitory 2
...at awards and accomplishments could have a profoun...car winners have been on an average found to live ...t the race and went home and empty-handed. The in...d actresses can be found in the latest issue of th...
...lular biologist who is the principle investigator ...of taste cells would help them to discover molecul...stes.// Researchers from the Monell Chemical Sense...eceptor cells outside the body. They have also bee...
...ly harms the teeth by way of discoloring them, it ...nal treatment, according to a new study // appeari...earch. "The findings substantiate what most of u...o your health," Elizabeth Krall Kaye, PhD, MPH, ep...
...PhD, with the Bradley Hasbro Children's Research C... effect of asthma on children. She said that // th...ving skills may be less likely to have their asthm...inspite of facing the stress related to urban scen...
Other Medicine News:Health News:Oscar Winners Live Longer Than Co-Competitors 2Health News:Functional Taste Cells Cultured In Vitro 2
...dy (IgG) Test is a semiquantitative enzyme immunoa...cant IgG antibodies to M. pneumoniae between acute...should not be used for specimens found reactive wi... Test and is not intended for qualitative (one spe...
...unoassay (EIA) that detects IgG antibodies to Epst...arr early nuclear antigen (EBV-EBNA), cytomegalovi...n with Mono-M Test it is an aid in the serodiagnos...ve serodiagnosis of CMV or Toxoplasma mononucleosi...
The ImmunoDOT TORCH Test is an enzyme immunoassay (EIA) procedure intended for determining the presence of antibodies to Toxoplasma gondii, rubella virus, cytomegalovirus and herpes simplex virus in
...e enzyme immunoassays (EIA) for the presumptive de... IgM, respectively) in serum. Equivocal or positiv...with a standardized western blot procedure. These ...ical diagnosis of B. burgdorferi infection (Lyme d...
Medicine Products: